Given that senescence and the expression of p16 were increased in kidneys of DM mice and DKD patients, it is reasonable to investigate whether clearance of p16-positive cells, most of them are senescent cells, decreases kidney injury and delays disease progression in DM mice. This evidence concerns the gene CDKN2A and diabetes mellitus.